Advantage of IFN-β/α2b same-day administration for ribavirin-intolerant patients with chronic hepatitis C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advantage of IFN-β/α2b same-day administration for ribavirin-intolerant patients with chronic hepatitis C

Published:2010-03 Issue:3 Volume:40 Page:261-268
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Tomita Eiichi,Ando Kazuki,Sugihara Jun-ichi,Nishigaki Youichi,Yamada Tetsuya,Ando Ryoko,Takemura Masao,Seishima Mitsuru

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1872-034X.2009.00602.x/fullpdf

Reference26 articles.

1. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection;Shiratori;Gastroenterology,1997

2. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy;Hagiwara;Gastroenterology,1993

3. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection;Enomoto;N Engl J Med,1996

4. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study;Dusheiko;J Hepatol,1996

5. Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial;Bellobuono;J Viral Hepat,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP